Abstract:Alzheimer's disease (AD) has become a global threat to the elderly health with a short survival time after diagnosis. Due to the asymptomatic stage during the early development, patients are usually diagnosed at the middle or late stage. Therefore, an efficient tool for AD early diagnosis deserves considerable attention, which could make a significant contribution to the treatment intervention. A fluorescent probe has been widely applied for detecting and visualizing species of interest in vitro and in vivo, and the proper reaction between the probe and analytes is responsible for the fluorescence change to provide a lighting-on or ratiometric responsive pattern with satisfactory sensing behavior. In this work, we report the first attempt to build up an AND-logic probe P2 for AD accuracy diagnosis taking butyrylcholinesterase (BChE) and reactive oxygen species (ROSs) as dual targets. Upon the co-stimulation by these two factors through enzymatic hydrolysis and redox reaction, the NIR emission could be readily turned on. This AND sensing pattern avoided the false-positive response effectively, and other diseases sharing one biomarker could hardly induce a NIR fluorescence response. The sensing assay has also been confirmed to be feasible in vitro and in vivo with good sensibility and selectivity. It is worth mentioning that the probe structure has been optimized in terms of the linkage length. This study shows that probe P2 with a connecting arm of medium length (one methylene, n = 1) has superior sensing performance, promising to provide a reference for the relative structure design.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.1c02943.Experimental section, 1H, 13C NMR, and HR-MS spectral copies of synthesized compounds (Figures S1–S13), fluorescence, and HR-MS spectral profiles (Figures S14–S25), cell cytotoxicity of P1–P3 (Figure S26), spectra of P4 toward ROSs (Figure S27), and living cell imaging of probe P4 (Figure S28) and in vivo imaging (Figure S29) (PDF)This article has not yet been cited by other publications.

Butyrylcholinesterase-Activated Near-Infrared Fluorogenic Probe for in Vivo Theranostics of Alzheimer's Disease.

Diagnosis of Alzheimer's Disease and in Situ Biological Imaging Via an Activatable Near-Infrared Fluorescence Probe.

Near-Infrared Aggregation-Induced Emission Luminogens for In Vivo Theranostics of Alzheimer's Disease.

Bioinspired Design of Highly Specific Fluorescent Probe for Butyrylcholinesterase Imaging in Living Cells and Alzheimer's Disease Model

Functional Insights from Targeted Imaging BACE1: the First Near-Infrared Fluorescent Probe for Alzheimer’s Disease Diagnosis

Design of an Activatable NIR-II Nanoprobe for the in Vivo Elucidation of Alzheimer's Disease-Related Variations in Methylglyoxal Concentrations.

Rational design synthesis and evaluation of a novel near-infrared fluorescent probe for selective imaging of amyloid-β aggregates in Alzheimer's disease

An Activatable Near-Infrared Fluorescent Probe for Methylglyoxal Imaging in Alzheimer's Disease Mice

Development of Near-Infrared Fluorescent Probes for Use in Alzheimer’s Disease Diagnosis

Advances in Design Strategies and Imaging Applications of Specific Butyrylcholinesterase Probes

An activatable near-infrared fluorescent probe with large Stokes shift for visualizing peroxynitrite in Alzheimer's disease models

An Activatable Near-Infrared Fluorescent Probe with Large Stokes Shift for Visualizing Peroxynitrite in Alzheimer’s Disease Models

Development of Near-Infrared Fluorescent Probes for Use in Alzheimers Disease Diagnosis

An Activatable NIR‐II Fluorescent Reporter for in Vivo Imaging of Amyloid‐β Plaques

Activity-Based NIR Specific Fluorescent Probe Reveals the Abnormal Elevation of Prolyl Endopeptidase in Hippocampus During Alzheimer's Disease Progression

A Novel Dual Fluorochrome Near-Infrared Imaging Probe for Potential Alzheimer’s Enzyme Biomarkers-BACE1 and Cathepsin D

A Novel Turn-on Near-Infrared Fluorescent Probe for Highly Sensitive in Vitro and in Vivo Detection of Acetylcholinesterase Activity

Real-time Fluorescent Determination and Biological Imaging in Living Models Via a Butyrylcholinesterase-Activated Fluorescent Probe

A far-red/near-infrared fluorescence probe with large Stokes shift for monitoring butyrylcholinesterase (BChE) in living cells and in vivo

AND-Logic Strategy for Accurate Analysis of Alzheimer’s Disease via Fluorescent Probe Lighted Up by Two Specific Biomarkers

Smart Near-Infrared Fluorescence Probes with Donor–Acceptor Structure for in Vivo Detection of Β-Amyloid Deposits